BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1504 related articles for article (PubMed ID: 23280319)

  • 1. Overall survival and development of stage IV chronic kidney disease in patients undergoing partial and radical nephrectomy for benign renal tumors.
    Kaushik D; Kim SP; Childs MA; Lohse CM; Costello BA; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
    Eur Urol; 2013 Oct; 64(4):600-6. PubMed ID: 23280319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Routine adrenalectomy in patients with locally advanced renal cell cancer does not offer oncologic benefit and places a significant portion of patients at risk for an asynchronous metastasis in a solitary adrenal gland.
    Weight CJ; Kim SP; Lohse CM; Cheville JC; Thompson RH; Boorjian SA; Leibovich BC
    Eur Urol; 2011 Sep; 60(3):458-64. PubMed ID: 21514718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A non-cancer-related survival benefit is associated with partial nephrectomy.
    Sun M; Trinh QD; Bianchi M; Hansen J; Hanna N; Abdollah F; Shariat SF; Briganti A; Montorsi F; Perrotte P; Karakiewicz PI
    Eur Urol; 2012 Apr; 61(4):725-31. PubMed ID: 22172373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses.
    Thompson RH; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Psutka SP; Stewart SB; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC
    Eur Urol; 2015 Feb; 67(2):252-9. PubMed ID: 25108580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of progression to end-stage renal disease requiring dialysis after partial or radical nephrectomy for renal cell carcinoma in patients with severe chronic kidney disease.
    Takagi T; Kondo T; Omae K; Iizuka J; Kobayashi H; Yoshida K; Hashimoto Y; Tanabe K
    Int Urol Nephrol; 2016 Sep; 48(9):1421-7. PubMed ID: 27193433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for acute kidney injury after radical nephrectomy and inferior vena cava thrombectomy for renal cell carcinoma.
    Shin S; Han Y; Park H; Chung YS; Ahn H; Kim CS; Cho YP; Kwon TW
    J Vasc Surg; 2013 Oct; 58(4):1021-7. PubMed ID: 23591189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up.
    Olweny EO; Park SK; Tan YK; Best SL; Trimmer C; Cadeddu JA
    Eur Urol; 2012 Jun; 61(6):1156-61. PubMed ID: 22257424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preserving Renal Function through Partial Nephrectomy Depends on Tumor Complexity in T1b Renal Tumors.
    Yoo S; You D; Jeong IG; Hong B; Hong JH; Kim CS; Ahn H; Song C
    J Korean Med Sci; 2017 Mar; 32(3):495-501. PubMed ID: 28145654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partial Nephrectomy Versus Radical Nephrectomy for Clinical T1b and T2 Renal Tumors: A Systematic Review and Meta-analysis of Comparative Studies.
    Mir MC; Derweesh I; Porpiglia F; Zargar H; Mottrie A; Autorino R
    Eur Urol; 2017 Apr; 71(4):606-617. PubMed ID: 27614693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kidney function following partial or radical nephrectomy for renal cell carcinoma: a population-based study.
    Mariusdottir E; Jonsson E; Marteinsson VT; Sigurdsson MI; Gudbjartsson T
    Scand J Urol; 2013 Dec; 47(6):476-82. PubMed ID: 23597159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nephron-sparing surgery is superior to radical nephrectomy in preserving renal function benefit even when expanding indications beyond the traditional 4-cm cutoff.
    Pignot G; Bigot P; Bernhard JC; Bouliere F; Bessede T; Bensalah K; Salomon L; Mottet N; Bellec L; Soulié M; Ferrière JM; Pfister C; Drai J; Colombel M; Villers A; Rigaud J; Bouchot O; Montorsi F; Bertini R; Belldegrun AS; Pantuck AJ; Patard JJ
    Urol Oncol; 2014 Oct; 32(7):1024-30. PubMed ID: 24996775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival after partial and radical nephrectomy for the treatment of stage T1bN0M0 renal cell carcinoma (RCC) in the USA: a propensity scoring approach.
    Badalato GM; Kates M; Wisnivesky JP; Choudhury AR; McKiernan JM
    BJU Int; 2012 May; 109(10):1457-62. PubMed ID: 21933334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partial vs Radical Nephrectomy for T1-T2 Renal Masses in the Elderly: Comparison of Complications, Renal Function, and Oncologic Outcomes.
    An JY; Ball MW; Gorin MA; Hong JJ; Johnson MH; Pavlovich CP; Allaf ME; Pierorazio PM
    Urology; 2017 Feb; 100():151-157. PubMed ID: 27889493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial nephrectomy for renal masses ≥ 7 cm: technical, oncological and functional outcomes.
    Long CJ; Canter DJ; Kutikov A; Li T; Simhan J; Smaldone M; Teper E; Viterbo R; Boorjian SA; Chen DY; Greenberg RE; Uzzo RG
    BJU Int; 2012 May; 109(10):1450-6. PubMed ID: 22221502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overall survival advantage with partial nephrectomy: a bias of observational data?
    Shuch B; Hanley J; Lai J; Vourganti S; Kim SP; Setodji CM; Dick AW; Chow WH; Saigal C;
    Cancer; 2013 Aug; 119(16):2981-9. PubMed ID: 23674264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-year oncologic and renal functional outcomes after robot-assisted partial nephrectomy.
    Khalifeh A; Autorino R; Eyraud R; Samarasekera D; Laydner H; Panumatrassamee K; Stein RJ; Kaouk JH
    Eur Urol; 2013 Nov; 64(5):744-50. PubMed ID: 23639721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small tumour size is associated with new-onset chronic kidney disease after radical nephrectomy in patients with renal cell carcinoma.
    Jeon HG; Choo SH; Sung HH; Jeong BC; Seo SI; Jeon SS; Choi HY; Lee HM
    Eur J Cancer; 2014 Jan; 50(1):64-9. PubMed ID: 24060356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New Chronic Kidney Disease and Overall Survival After Nephrectomy for Small Renal Cortical Tumors.
    Mashni JW; Assel M; Maschino A; Russo M; Masi B; Bernstein M; Huang WC; Russo P
    Urology; 2015 Dec; 86(6):1137-43. PubMed ID: 26362947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma.
    Van Poppel H; Da Pozzo L; Albrecht W; Matveev V; Bono A; Borkowski A; Colombel M; Klotz L; Skinner E; Keane T; Marreaud S; Collette S; Sylvester R
    Eur Urol; 2011 Apr; 59(4):543-52. PubMed ID: 21186077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of Renal Functional Outcomes After Radical or Partial Nephrectomy for Renal Masses ≥7 cm Using the RENAL Score.
    Kopp RP; Liss MA; Mehrazin R; Wang S; Lee HJ; Jabaji R; Mirheydar HS; Gillis K; Patel N; Palazzi KL; Wan JY; Patterson AL; Derweesh IH
    Urology; 2015 Aug; 86(2):312-9. PubMed ID: 26189330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 76.